Up nearly 40% in 2 days: What's fuelling this pharma stock's rally
Cohance Lifesciences shares surged after the company named Umang Vohra as Executive Chairman and Group CEO. The move lifted expectations of faster growth, stronger execution and bigger scale in its CDMO business.

What's Your Reaction?











